These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8137408

  • 1. [Epidemiologic studies on HCV and HBV infections among intravenous drug users in the area with high HIV infection].
    Cheng H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):275-8. PubMed ID: 8137408
    [Abstract] [Full Text] [Related]

  • 2. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS, Brajachand N, Singh HL, Singh YM.
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [Abstract] [Full Text] [Related]

  • 3. [Prevalence of HIV and HCV among injecting drug users (IDUs) in Yunnan, China].
    Li D, Zheng X, Zhang G.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):74-5. PubMed ID: 7522968
    [Abstract] [Full Text] [Related]

  • 4. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V, Zimatore G, Izzi A, Caroleo B, Rocca A, Montesano F, Costa C, Masciari R, Naso E, Biselli R.
    J Clin Lab Immunol; 1995 Apr; 47(1):1-9. PubMed ID: 8735431
    [Abstract] [Full Text] [Related]

  • 5. [A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users].
    Wang YC, Xu SH, Li XH, Song AJ, Jia XR, Zhuang H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):777-9. PubMed ID: 17299963
    [Abstract] [Full Text] [Related]

  • 6. Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users.
    Wu N, Li D, Zhu B, Zou W.
    Chin Med J (Engl); 2003 Sep; 116(9):1318-20. PubMed ID: 14527356
    [Abstract] [Full Text] [Related]

  • 7. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, Carbonara S, Monarca R, Quercia G, Florenzano G, Novati S, Sardu A, Iovinella V, Casti A, Romano A, Uccella I, Maida I, Brunetti B, Mura MS, Andreoni M, Rezza G.
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG, Cyprus IVDU Network, Kostrikis LG.
    J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
    [Abstract] [Full Text] [Related]

  • 9. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
    Imani R, Karimi A, Rouzbahani R, Rouzbahani A.
    East Mediterr Health J; 2008 Feb; 14(5):1136-41. PubMed ID: 19161086
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T, Ahmed T, Iqbal A, Islam M, Islam MN.
    J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
    [Abstract] [Full Text] [Related]

  • 11. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L, Chant K, Jalaludin B, Sargent P.
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Oct; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S.
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [Abstract] [Full Text] [Related]

  • 14. [The serologic study on the blood transmission origin of HIV].
    Zhu B, Wu N, Qiang L, Shao Y.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):140-2. PubMed ID: 11860777
    [Abstract] [Full Text] [Related]

  • 15. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
    Rodríguez-Méndez ML, González-Quintela A, Aguilera A, Carballo E, Barrio E.
    Hepatogastroenterology; 2003 Apr; 50(54):2093-7. PubMed ID: 14696471
    [Abstract] [Full Text] [Related]

  • 16. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I.
    AIDS; 1996 Mar; 10(3):311-7. PubMed ID: 8882671
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
    Jindal N, Arora U, Singh K.
    Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [HBV, HCV and HIV infections among drug addicts-residents of rehabilitation and social adjustment centers in the Gdańsk district].
    Smiatacz T, Własiuk M, Paszkiewicz J, Zielińska W.
    Przegl Epidemiol; 1991 Jan; 45(4):351-5. PubMed ID: 1841415
    [Abstract] [Full Text] [Related]

  • 20. [A sero-epidemiological study of HCV and HBV infection among intravenous drug abusers].
    Yang Y, Zhang G, Xu Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Sep 30; 13(3):247-50. PubMed ID: 12569756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.